Profund Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $458K | Sell |
32,669
-1,069
| -3% | -$15K | 0.02% | 489 |
|
|
2025
Q1 | $528K | Sell |
33,738
-7,285
| -18% | -$114K | 0.02% | 454 |
|
|
2024
Q4 | $571K | Sell |
41,023
-13,559
| -25% | -$189K | 0.02% | 446 |
|
|
2024
Q3 | $508K | Buy |
54,582
+6,392
| +13% | +$59.4K | 0.02% | 525 |
|
|
2024
Q2 | $448K | Sell |
48,190
-78,093
| -62% | -$726K | 0.02% | 537 |
|
|
2024
Q1 | $1.25M | Buy |
+126,283
| New | +$1.25M | 0.05% | 299 |
|
|
2023
Q4 | – | Sell |
-69,926
| Closed | -$371K | – | 1133 |
|
|
2023
Q3 | $371K | Sell |
69,926
-19,854
| -22% | -$105K | 0.02% | 562 |
|
|
2023
Q2 | $856K | Buy |
89,780
+33,590
| +60% | +$320K | 0.05% | 350 |
|
|
2023
Q1 | $618K | Buy |
+56,190
| New | +$618K | 0.04% | 441 |
|